Franklin Biotechnology Discv B Acc $ (USD)

Performance History30/04/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv B Acc $ (USD)
Fund100.046.838.8-28.59.9
+/-Cat5.02.8-4.80.5-1.0
+/-Idx-7.02.4-5.4-6.02.4
 
Key Stats
NAV
28/04/2017
 USD 24.55
Day Change 0.47%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394881
Fund Size (Mil)
31/03/2017
 USD 2447.07
Share Class Size (Mil)
31/03/2017
 USD 22.37
Max Initial Charge -
Ongoing Charge
27/01/2017
  3.14%
Investment Objective: Franklin Biotechnology Discv B Acc $ (USD)
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns28/04/2017
YTD9.91
3 Years Annualised18.27
5 Years Annualised30.27
10 Years Annualised18.16
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
03/04/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv B Acc $ (USD)31/03/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks93.730.0093.73
Bonds0.000.000.00
Cash5.090.005.09
Other1.170.001.17
Top 5 Regions%
United States96.91
United Kingdom0.97
Middle East0.87
Eurozone0.68
Canada0.36
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.53
Biogen IncHealthcareHealthcare6.48
Incyte CorpHealthcareHealthcare6.21
Alexion Pharmaceuticals IncHealthcareHealthcare5.70
Tesaro IncHealthcareHealthcare5.25
Franklin Biotechnology Discv B Acc $ (USD)